📑NFPPAP Imunoglobulina antirabica umana
Procurement process summary
This process is to purchase NFPPAP Imunoglobulina antirabica umana.
This contract was awarded by 🇷🇴 Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș" for an amount of RON 27,510 to 1 supplier. It was published on 2024-05-24 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇷🇴 Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș" Publication date2024-05-24 DescriptionNFPPAP Imunoglobulina antirabica umanaAwards
This award was granted to TORUS PHARMA COMPANY SRL by Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș" for an amount of RON 27,510. The procurement process was conducted through direct for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇷🇴 TORUS PHARMA COMPANY SRL | RON 27,510 | 1 |
Market context and opportunities
The execution of this contract allows the entity Institutul Național de Boli Infecțioase "Prof. Dr. Matei Balș" to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberRO_ocds-70d2nz-82dde86d-eade-49da-9f77-43cd359b265c-award-1Publication date2024-05-24CategoriesgoodsPurchase modalitydirectMethod detailsNegociere fara publicare prealabilaData sources
This website publishes data from official sources, public databases published by governments. Public access to data is a civil right. The data helps citizen monitor of government spending. The data here is public by law. It does not contain personal data. There is no privacy violation. Privacy policy.
